what is in glp 1 drugs GLP-1 Agonists: A Comprehensive Overview Glucagon-like peptide-1 - Wikipedia

Low levels can cause a loss of balance, numbness or tingling in the arms and legs, weakness, fatigue, constipation, confusion, depression, poor memory, soreness of the mouth or tongue, weight loss, and a type of anemia known as megaloblastic anemia

Tirzepatide is administered as a once-weekly subcutaneous injection, with a recommended starting dose of 2.5 mg once weekly for 4 weeks, then increasing by 2.5 mg every 4 weeks until the target dose (up to 15 mg) is reached

In conclusion, we have developed a facile protocol to hydrophobize GSH-AuNCs and to efficiently encapsulate them into PLGA nanocarriers with maintained photoluminescence properties and minimal leaching

doi: 10.1136/bjsports-2020-102955 57 OzemekCBonikowskeARChristleJWGalloPM